Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
Innoviva Dividend Announcement
• Innoviva announced a quarterly dividend of $0.25 per ordinary share which will be made payable on 2015-09-30. Ex dividend date: 2015-09-08
• Innoviva's trailing twelve-month (TTM) dividend yield is -%
Innoviva Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2015-09-08 | $0.25 | quarterly | 2015-09-30 |
2015-06-10 | $0.25 | quarterly | 2015-06-30 |
2015-03-10 | $0.25 | quarterly | 2015-03-31 |
2014-11-21 | $0.25 | quarterly | 2014-12-23 |
2014-08-26 | $0.25 | quarterly | 2014-09-18 |
Innoviva Dividend per year
Innoviva Dividend Yield
Innoviva current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Innoviva stock? Use our calculator to estimate your expected dividend yield:
Innoviva Financial Ratios
Innoviva Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Innoviva stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.